Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

5-Azacytidine treatment in a beta (0)-thalassaemic patient unable to be transfused due to multiple alloantibodies.

Dunbar C, Travis W, Kan YW, Nienhuis A.

Br J Haematol. 1989 Jul;72(3):467-8. No abstract available.

PMID:
2475157
[PubMed - indexed for MEDLINE]
2.

[Pharmacological correction of genetic defects - azacytidine in the treatment of thalassemia].

Kuratowska Z.

Pol Tyg Lek. 1983 Jun 13;38(24):713-5. Polish. No abstract available.

PMID:
6196764
[PubMed - indexed for MEDLINE]
3.

5-azacytidine for beta-thalassemia?

Clegg JB, Weatherall DJ, Bodmer WF.

Lancet. 1983 Mar 5;1(8323):536. No abstract available.

PMID:
6186875
[PubMed - indexed for MEDLINE]
4.

5-azacytidine for beta-thalassaemia?

[No authors listed]

Lancet. 1983 Jan 1;1(8314-5):36-7. No abstract available.

PMID:
6184580
[PubMed - indexed for MEDLINE]
5.

Red cell immunization in multiply transfused Malay thalassemic patients.

Noor Haslina MN, Ariffin N, Illuni Hayati I, Rosline H.

Southeast Asian J Trop Med Public Health. 2006 Sep;37(5):1015-20.

PMID:
17333748
[PubMed - indexed for MEDLINE]
6.

5-azacytidine for beta thalassaemia?

Ley TJ, Anagnou NP, Young NS, Nienhuis AW, DeSimone J, Heller P.

Lancet. 1983 Feb 26;1(8322):467. No abstract available.

PMID:
6186873
[PubMed - indexed for MEDLINE]
7.

5-Azacytidine and fetal hemoglobin.

Heller P, DeSimone J.

Am J Hematol. 1984;17(4):439-47. Review.

PMID:
6208778
[PubMed - indexed for MEDLINE]
8.

5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia.

Ley TJ, DeSimone J, Noguchi CT, Turner PH, Schechter AN, Heller P, Nienhuis AW.

Blood. 1983 Aug;62(2):370-80.

PMID:
6191799
[PubMed - indexed for MEDLINE]
Free Article
9.

Altering gene expression with 5-azacytidine.

Jones PA.

Cell. 1985 Mar;40(3):485-6. Review. No abstract available.

PMID:
2578884
[PubMed - indexed for MEDLINE]
10.

Brief report: treatment with azacitidine of patients with end-stage beta-thalassemia.

Lowrey CH, Nienhuis AW.

N Engl J Med. 1993 Sep 16;329(12):845-8. No abstract available.

PMID:
7689171
[PubMed - indexed for MEDLINE]
Free Article
11.

Controlling the fetal globin switch in man.

Orkin SH.

Nature. 1983 Jan 13;301(5896):108-9. No abstract available.

PMID:
6185847
[PubMed - indexed for MEDLINE]
12.

Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent.

Singer ST, Wu V, Mignacca R, Kuypers FA, Morel P, Vichinsky EP.

Blood. 2000 Nov 15;96(10):3369-73.

PMID:
11071629
[PubMed - indexed for MEDLINE]
Free Article
13.

5-Azacytidine acts directly on both erythroid precursors and progenitors to increase production of fetal hemoglobin.

Humphries RK, Dover G, Young NS, Moore JG, Charache S, Ley T, Nienhuis AW.

J Clin Invest. 1985 Feb;75(2):547-57.

PMID:
2579100
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Early onset multiple alloimmunization (anti-E and anti-Jkb) in a thalassaemic.

Thakral B, Saluja K, Sharma RR, Marwaha N, Marwaha RK.

Clin Lab Haematol. 2006 Aug;28(4):286-7. No abstract available.

PMID:
16898974
[PubMed - indexed for MEDLINE]
15.

Transfusion medicine in a developing country - alloantibodies to red blood cells in multi-transfused patients in Saudi Arabia.

Gader AG, Al Ghumlas AK, Al-Momen AK.

Transfus Apher Sci. 2008 Dec;39(3):199-204. doi: 10.1016/j.transci.2008.09.013. Epub 2008 Oct 23.

PMID:
18951063
[PubMed - indexed for MEDLINE]
16.

Erythrocyte, leucocyte and platelet antibodies in polytransfused thalassaemic patients.

Augoustaki O, Constantoulakis M.

Bibl Haematol. 1968;29:494-500. No abstract available.

PMID:
5727706
[PubMed - indexed for MEDLINE]
17.

Comment on 'Red cell alloantibodies in patients with thalassemia' (Spanos et al.)

Michail-Merianou V.

Vox Sang. 1992;62(3):190. No abstract available.

PMID:
1609522
[PubMed - indexed for MEDLINE]
18.

Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?

Fathallah H, Sutton M, Atweh GF.

Ann N Y Acad Sci. 2005;1054:228-37. Review.

PMID:
16339670
[PubMed - indexed for MEDLINE]
19.

[Anti-leukocyte isoantibodies in multitransfused thalassemic children (with special reference to cytotoxic antibodies)].

Morgese G, Pindinelli CA, Bianchini AM, Messina G.

Riv Clin Pediatr. 1968 Sep-Oct;81(5):758-71. Italian. No abstract available.

PMID:
5740204
[PubMed - indexed for MEDLINE]
20.

Alloimmunization against human platelet antigen 2 (HPA2) in a series of multi-transfused beta-thalassemia patients.

Tazzari PL, Ricci F, Tassi C, Bontadini A, Fruet F, Conte R.

Haematologica. 1998 Aug;83(8):765-6.

PMID:
9793272
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk